bioRxivNeurosciencePreprint
Enhanced mTORC1 signaling and Protein Synthesis in Parkinson Disease Pathogenesis
Mohammed Repon KhaniD, Xiling YiniD, Sung-Ung KangiD, Jaba MitraiD, Hu WangiD, Saurav BrahmachariiD, Senthilkumar S. KaruppagounderiD, Yasuyoshi KimuraiD, Aanishaa JhaldiyaliD, Hyun Hee KimiD, Hao Gu, Rong CheniD, Javier Redding‐OchoaiD, Juan Carlos TroncosoiD, Taekjip HaiD, Valina Lynn DawsoniD, Ted M. DawsoniD
Abstract
Pathologic -syn destabilizes the TSC 1 and 2 complex leading to mTORC1 activation, enhanced protein translation and neurodegeneration in PD. AbstractPathological -synuclein (-syn) plays an important role in the pathogenesis of -synucleinopathies such as Parkinsons disease (PD). Disruption of protein homeostasis is thought be central to PD pathogenesis, however the molecular mechanism of this deregulation is poorly understood. Here we report that pathologic -syn binds to tuberous sclerosis protein (TSC) 2 and destabilizes the TSC1-TSC2 complex leading to activation of the mechanistic target of rapamycin (mTOR) complex 1 (mTORC1) and enhanced mRNA translation. Dopamine neuron loss, behavioral deficits and aberrant biochemical signaling in the -syn preformed fibril (PFF) and Drosophila -syn transgenic models of pathologic -syn induced degeneration were attenuated by genetic and pharmacologic inhibition of mTOR and protein translation. Our findings establish a potential molecular mechanism by which pathologic -syn activates mTORC1 leading to enhanced protein translation and concomitant neurodegeneration in PD.
- organism: mouse
- organism: Drosophila
- assay: proteomics
- assay: multiome
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- approach: statistical model
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- DAPK1-mediated parkin inactivation enhances neurotoxicity via MITOL-dependent degradation
Chul Hong Park, Donghyuk Shin, Kwang Chul Chung·Journal of Cellular and Molecular MedicinePeer-reviewed·Apr 1, 2026
- Complement and coagulation cascades are potentially involved in dopaminergic neurodegeneration in alpha-synuclein-based mouse models of Parkinson's disease
Shi-Xun Ma, Bo Am Seo, … Han Seok Ko·Journal of Proteome ResearchPeer-reviewed·Jun 1, 2021
- Aberrant FICD-mediated AMPylation drives α-Synuclein pathology and overall protein dyshomeostasis in dopaminergic neurons in Parkinson's disease
Aron Koller, Laura Hoffmann, … Wei Xiang·bioRxiv·Apr 1, 2026
- Tet2 loss suppress α-synuclein pathology by stimulating ciliogenesis
Emmanuel Quansah, Naman Vatsa, … Juozas Gordevičius·bioRxiv·Aug 2, 2024
- Pharmacological PINK1 activation ameliorates Pathology in Parkinson's Disease models
R Chin, Rishi Rakhit, … Nicholas T. Hertz·bioRxiv·Feb 14, 2023
- Pathological levels of α-synuclein increase basal mitophagy in Parkinson's dopamine neurons
E. D. Mock, B. Vallin, … R. Wade-Martins·bioRxiv·Nov 2, 2026